You are viewing the site in preview mode
Skip to main content
|
Study
|
Age
|
gender
|
Symptoms
|
Tumor
|
LH (mIU/mL)
|
a-subunit (ng/ml)
|
FSH (mIU/mL)
|
E2(pg/ml)
|
T (ng/ml)
|
Medical therapy
|
Operation
|
|---|
|
Peterso [2]
|
30
|
Male
|
azzospermic
|
Intrasellar mass
|
207 (6–26)
|
72(< 0.5–2.5)
|
2(normal range 5–25)
|
110(< 10–60)
|
1500 (300–1000)
|
TRH, LRH, L-dopa, metyrapone,
|
Transsphenoidal operation
|
|
Klibanski [3]
|
48
|
Male
|
Increase in libido, blind
|
Pituitary tumor
|
99 (2–18)
|
5.7(< 2.5)
|
5.5(−)
|
219(< 52)
|
1660 (300–1100)
| |
Transfrontal craniotomy
|
|
Vos [4]
|
20
|
Male
|
Grand-mal seizures
|
Hypothalamic-pituitary tumor
|
140 (2–15)
|
9105 (3–30)
|
4 (3–12)
| |
53 (12–30)
|
SMS201–995
|
Transsphenoidal operation
|
|
Castelo-Branco [5]
|
31
|
Female
|
OHSS
|
Pituitary macroadenoma
|
4.9(−)
| |
7.2(−)
| | |
Prolactin, cabergoline, somatostatin
|
Transsphenoidal operation
|
|
Roman [6]
|
33
|
Male
|
Testicular pain, dysuria
|
Intrasellar mass
|
207 (3–9)
|
72(< 0.5–2.5)
|
2 (4–11)
| |
15,000 (30000–80,000)
|
LHRH
|
Transsphenoidal operation
|
|
Kadakia [7]
|
9
|
Male
|
Precocious puberty
|
Anterior pituitary tumor
|
5(< 0.49)
| |
< 0.05 (0.87–9.16)
| |
44,200(< 4200)
|
leuprolide
|
Transsphenoidal operation
|
- LH Luteinizing Hormone, FSH Follicle stimulating hormone, E2 estradiol, T Testosterone, SMS somatostatin, OHSS ovarian hyperstimulation syndrome